Comparison between Kenrik Industries IPO and Speciality Medicines IPO.
Kenrik Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Speciality Medicines IPO is a SME Bookbuilding proposed to list at BSE SME.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Turnaround Corporate Advisors Pvt.Ltd. | Unistone Capital Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Mnm Stock Broking Pvt.Ltd. | Aikyam Capital Private Limited |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Kenrik Industries IPO is up to ₹8.30 Cr whereas the issue size of the Speciality Medicines IPO is up to ₹27.28 Cr. The final issue price of Kenrik Industries IPO is ₹25.00 per share and of Speciality Medicines IPO is ₹124.00 per share.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹117.00 per share | |
| Issue Price (Upper) | ₹124.00 per share | |
| Issue Price (Final) | ₹25.00 per share | ₹124.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 1000 shares |
| Fresh Issue Size | 33,18,000 shares | 22,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.30 Cr | up to ₹27.28 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 33,18,000 shares | 22,00,000 shares |
| Issue Size Total (Amount) | up to ₹8.30 Cr | up to ₹27.28 Cr |
Kenrik Industries IPO opens on Apr 29, 2025, while Speciality Medicines IPO opens on Mar 20, 2026. The closing date of Kenrik Industries IPO and Speciality Medicines IPO is May 06, 2025, and Mar 24, 2026, respectively.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 29, 2025 | Mar 20, 2026 |
| Issue Close | May 06, 2025 | Mar 24, 2026 |
| Basis Of Allotment (Tentative) | May 07, 2025 | Mar 25, 2026 |
| Initiation of Refunds (Tentative) | May 08, 2025 | Mar 27, 2026 |
| Credit of Share (Tentative) | May 08, 2025 | Mar 27, 2026 |
| Listing date (Tentative) | May 09, 2025 | Mar 30, 2026 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Kenrik Industries IPO P/E ratio is 20.74, as compared to Speciality Medicines IPO P/E ratio of 9.27.
| Kenrik Industries IPO | Speciality Medicines IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 59.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.01 | 43.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.74 | 9.27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31.24 Cr. | ₹108.94 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.01 | 37.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.85 | 33.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.06 | 0.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.21 | ₹13.38 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 8.62 | 28.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Kenrik Industries IPO Retail Individual Investors (RII) are offered 16,62,000 shares while in Speciality Medicines IPO retail investors are offered 16,62,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Kenrik Industries IPO and 21,000 shares in Speciality Medicines IPO.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 1,80,000 shares | 1,50,000 shares |
| QIB | 0 shares | 21,000 shares |
| NII | 16,56,000 shares | 10,89,000 shares |
| RII | 16,62,000 shares | 10,90,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 33,18,000 shares | 22,00,000 shares |
Kenrik Industries IPO subscribed 2.00x in total, whereas Speciality Medicines IPO subscribed 2.27x.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| QIB (times) | 96.24x | |
| NII (times) | 0.20x | 1.88x |
| Big NII (times) | 2.50x | |
| Small NII (times) | 0.64x | |
| RII (times) | 3.79x | 0.85x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.00x | 2.27x |
